Schedule 13G ownership disclosure

NEKTAR THERAPEUTICS

Common Stock, par value $0.0001 per share · CUSIP: 640268108

Event date: 2025-06-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP II, LLC

    Shares: 1,933,333 · Class: 9.3%

  • TCG Crossover Fund II, L.P.

    Shares: 1,933,333 · Class: 9.3%

  • Chen Yu

    Shares: 1,933,333 · Class: 9.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-108881
Form type
SCHEDULE 13G/A
Filer
NEKTAR THERAPEUTICS
CIK
CIK 906709
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub